Sign inGet started

YINGLING JONATHAN MICHAEL

Insider CIK 1660011 · BIND Chief Scientific Officer · IDRA SVP, Early Development

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2020-01-102020-01-1450,000— $050,000SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award2020-01-102020-01-1420,000— $036,358SEC↗
IDRA IDERA PHARMACEUTICALS, INC S Sale2020-01-072020-01-101,742$1.78 $3.1K16,358SEC↗
IDRA IDERA PHARMACEUTICALS, INC S Sale2020-01-072020-01-141,742$1.78 $3.1K16,358SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2019-07-092019-07-1145,500— $045,500SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2019-01-032019-01-0745,500— $045,500SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award2019-01-032019-01-0718,100— $018,100SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2018-08-132018-08-1532,500— $032,500SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2018-01-032018-01-05270,000$2.24 $604.8K270,000SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2017-02-062017-02-08275,000— $0275,000SEC↗
IDRA IDERA PHARMACEUTICALS, INC A Award deriv2017-02-062017-02-08325,000— $0325,000SEC↗
BIND BIND Therapeutics, Inc A Award deriv2015-12-142015-12-16200,000— $0200,000SEC↗